Literature DB >> 8403511

Transforming growth factor-beta (TGF-beta) in human milk.

S Saito1, M Yoshida, M Ichijo, S Ishizaka, T Tsujii.   

Abstract

The amount of TGF-beta contained in human whey was studied by the colony formation of NRK47F cells. It was noted that a factor inducing colony formation did exist in human whey, and its action was neutralized when anti-TGF-beta antibodies were introduced. This suggests that TGF-beta does exist in human whey. In colostrum, the total amount of TGF-beta was 1365.7 +/- 242.9 ng/ml, of which the active form comprised 728.1 +/- 248.7 ng/ml (n = 21). In late milk, the total TGF-beta was 952.5 +/- 212.6 ng/ml, with an active form of 178.7 +/- 157.3 ng/ml. Thus human milk contains a large amount of active TGF-beta. Furthermore, it was revealed by the reverse transcriptase polymerase chain reaction that mRNAs coding TGF-beta 1 and TGF-beta 2 exist in human milk cells. These results suggest that both TGF-beta 1 and TGF-beta 2 exist in human milk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403511      PMCID: PMC1534356          DOI: 10.1111/j.1365-2249.1993.tb06004.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Transforming growth factor activity in human colostrum.

Authors:  K Noda; M Umeda; T Ono
Journal:  Gan       Date:  1984-02

3.  Serum contains a platelet-derived transforming growth factor.

Authors:  C B Childs; J A Proper; R F Tucker; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

4.  Predictive value of cord blood IgE in the development of atopic disease and role of breast-feeding in its prevention.

Authors:  R K Chandra; S Puri; P S Cheema
Journal:  Clin Allergy       Date:  1985-11

Review 5.  Regulation of mammary growth and function by TGF-beta.

Authors:  C W Daniel; S D Robinson
Journal:  Mol Reprod Dev       Date:  1992-06       Impact factor: 2.609

6.  Partial purification of transforming growth factors from human milk.

Authors:  J A Zwiebel; M Bano; E Nexo; D S Salomon; W R Kidwell
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

7.  Transforming growth factors in the urine of normal, pregnant, and tumor-bearing humans.

Authors:  D R Twardzik; S A Sherwin; J Ranchalis; G J Todaro
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

8.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

9.  Isolation and characterization of epidermal growth factor from human milk.

Authors:  P E Petrides; M Hosang; E Shooter; F S Esch; P Böhlen
Journal:  FEBS Lett       Date:  1985-07-22       Impact factor: 4.124

10.  Isolation of colony stimulating factor from human milk.

Authors:  S K Sinha; A A Yunis
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

View more
  30 in total

Review 1.  Effect of breast milk and weaning on epithelial growth of the small intestine in humans.

Authors:  A G Cummins; F M Thompson
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

Review 2.  Enterocytes: active cells in tolerance to food and microbial antigens in the gut.

Authors:  N Miron; V Cristea
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Host factors in amniotic fluid and breast milk that contribute to gut maturation.

Authors:  Carol L Wagner; Sarah N Taylor; Donna Johnson
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

4.  Milk cytokines and subclinical breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil supplementation.

Authors:  S M Filteau; G Lietz; G Mulokozi; S Bilotta; C J Henry; A M Tomkins
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

5.  Oral administration of transforming growth factor-β1 (TGF-β1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor κB (NF-κB) signaling and proinflammatory cytokine production.

Authors:  Sheng-Ru Shiou; Yueyue Yu; Yuee Guo; Maria Westerhoff; Lei Lu; Elaine O Petrof; Jun Sun; Erika C Claud
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

6.  Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Authors:  F M Kong; M S Anscher; T Murase; B D Abbott; J D Iglehart; R L Jirtle
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

7.  Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-beta.

Authors:  S Ishizaka; M Kimoto; S Kanda; S Saito
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

8.  Immune activation during infancy in healthy humans.

Authors:  A G Cummins; B A Eglinton; A Gonzalez; D M Roberton
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

9.  Maternal milk regulation of cell infiltration and interleukin 18 in the intestine of suckling rat pups.

Authors:  I A Penttila; I E A Flesch; A L McCue; B C Powell; F H Zhou; L C Read; H Zola
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

10.  N-terminal site-specific mono-PEGylation of epidermal growth factor.

Authors:  Haeshin Lee; Il Ho Jang; Sung Ho Ryu; Tae Gwan Park
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.